ABI-008

· Celgene

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABI-008, covering 2019-11-22 to 2019-11-22. Get the full timeline:

Most recent: Clinical Trial Update: ABI-008 Trial in Patients With Hormone-refractory Prostate Cancer [Phase 1, Phase 2]